Next Generation Labs (NGL) has been the innovator in synthetic nicotine development since 2014 and has led the advance in the use of synthetic nicotine that now offers adult consumers access to nicotine that is free of all tobacco-derived constituents, contaminants and residuals. NGL developed the first bulk patented manufacturing process for high quality pure synthetic nicotine sold under the brand name TFN and Pharmanic for the tobacco, vape and pharmaceutical industries. The company has both patented and proprietary methods for producing R-S, R and S-form isomer synthetic nicotine. NGL is the global leader in bulk synthetic nicotine manufacture, product development and product testing protocols. NGL’s TFN branded S and R-S and R nicotine isomers have become industry standards for brand manufacturers of vape, oral nicotine and heat not burn products worldwide. NGL currently holds a number of worldwide process and methods patents for the manufacture of synthetic nicotine and the use of R and S isomer nicotine combinations in smoking cessation products.
Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the
If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:
+44 (0)20 7936 6948